These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6903544)

  • 1. Urinary continence/incontinence. Nursing implications of drug therapy. Close observation for both expected and unexpected effects is a must.
    Cotterell M; Miller M
    Geriatr Nurs; 1980; 1(4):271-4, 276. PubMed ID: 6903544
    [No Abstract]   [Full Text] [Related]  

  • 2. Case 7: the addled nonagenarian.
    Shader RI; Oesterheld JR
    J Clin Psychopharmacol; 1995 Oct; 15(5):378. PubMed ID: 8830074
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary incontinence--treatment].
    Hader C; Welz-Barth A; Keller T
    Dtsch Med Wochenschr; 2003 Apr; 128(14):750-2. PubMed ID: 12673531
    [No Abstract]   [Full Text] [Related]  

  • 4. Low dose oxybutynin for the unstable bladder.
    Malone-Lee J; Lubel D; Szonyi G
    BMJ; 1992 Apr; 304(6833):1053. PubMed ID: 1586797
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravesical instillation of oxybutynin in women with idiopathic detrusor instability: a randomised trial.
    Enzelsberger H; Helmer H; Kurz C
    Br J Obstet Gynaecol; 1995 Nov; 102(11):929-30. PubMed ID: 8534633
    [No Abstract]   [Full Text] [Related]  

  • 6. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo-controlled trial.
    Ouslander JG; Schnelle JF; Uman G; Fingold S; Nigam JG; Tuico E; Jensen BB
    J Am Geriatr Soc; 1995 Jun; 43(6):610-7. PubMed ID: 7775717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary incontinence due to interaction of phenoxybenzamine and alpha-methyldopa.
    Fernandez PG; Sahni S; Galway BA; Granter S; McDonald J
    Can Med Assoc J; 1981 Jan; 124(2):174-5. PubMed ID: 7459779
    [No Abstract]   [Full Text] [Related]  

  • 8. Emepronium bromide in the management of nightly urinary frequency and urinary incontinence.
    Kagan G
    Practitioner; 1970 May; 204(223):705-10. PubMed ID: 5431337
    [No Abstract]   [Full Text] [Related]  

  • 9. Imipramine--a possible alternative to current therapy for urinary incontinence in the elderly.
    Castleden CM; George CF; Renwick AG; Asher MJ
    J Urol; 1981 Mar; 125(3):318-20. PubMed ID: 7009892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release.
    Staskin DR; Cardozo L
    Int J Clin Pract; 2009 Jun; 63(6):973-6. PubMed ID: 19459997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary continence/incontinence. Helpful drugs: depending on the cause of incontinence, medication may be the answer.
    Finkbeiner AE
    Geriatr Nurs; 1980; 1(4):270-1. PubMed ID: 6903543
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind study of imipramine and placebo for incontinence due to bladder instability.
    Castleden CM; Duffin HM; Gulati RS
    Age Ageing; 1986 Sep; 15(5):299-303. PubMed ID: 3535446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary incontinence: which drugs to use.
    Westmore DD
    Drugs; 1979 May; 17(5):418-22. PubMed ID: 456295
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravesical drug therapy in women with severe urge incontinence. Clinical experiences from a department of gynecology].
    Johansen JK; Lose G
    Ugeskr Laeger; 1999 Nov; 161(44):6052-5. PubMed ID: 10778341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication: its role in the cause and treatment of urinary incontinence.
    DeRidder PA; Vallerand HG
    J Enterostomal Ther; 1986; 13(5):187-9. PubMed ID: 2876016
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticholinergic therapy of urinary incontinence and urinary frequency associated with the elderly--with special reference to dementia].
    Sugiyama T; Matsuda H; Oonishi N; Kiwamoto H; Esa A; Park YC; Kurita T; Uchida A; Kunikata S
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1068-73. PubMed ID: 8345723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of terodiline hydrochloride for the treatment of urinary frequency and urinary incontinence, and its cardiovascular adverse effects].
    Yoshihara H; Yasumoto R; Kishimoto T; Maekawa M; Horii A; Nishijima T; Sugimoto T; Kashiwara N; Tsujita M; Senjyu M
    Hinyokika Kiyo; 1992 Aug; 38(8):967-72. PubMed ID: 1414748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terodiline. A review of its pharmacological properties, and therapeutic use in the treatment of urinary incontinence.
    Langtry HD; McTavish D
    Drugs; 1990 Nov; 40(5):748-61. PubMed ID: 2292235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting urinary continence in older women.
    Bardsley A
    Nurs Stand; 2014 Oct; 29(8):42-51. PubMed ID: 25335630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study].
    Enzelsberger H; Kurz C; Helmer H; Mittermayer F
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):240-3. PubMed ID: 7607378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.